Raport roczny Fundacji IOZK: Consilium 24/25

The Complexity of Malignant Glioma Treatment

Webinarium IOZK podczas World Cancer Series

Wywiad z prof. dr Volkerem Schirrmacherem w Klassik Radio

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

Nowa publikacja IOZK na temat płynnej biopsji

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

The Application of Evidence-Based Medicine in Individualized Medicine